TYRA BIOSCIENCES INC (TYRA) Stock Income Statement
NASDAQ:TYRA - Nasdaq - US90240B1061 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 104.18M | 79.94M | 58.93M | 26.29M | 9.30M | |||
| Research and Development | 80.08M | 62.52M | 43.01M | 20.63M | 7.19M | |||
| Selling, General, and Administrative Expenses | 24.10M | 17.43M | 15.92M | 5.65M | 2.09M | |||
| Operating Income | -104.18M | -79.94M | -58.93M | -26.29M | -9.30M | |||
| Interest Income/Expense | 17.70M | 10.85M | 3.65M | 10.00K | 0.00 | |||
| Other Income/Expense | N/A | -39.00K | -50.00K | -20.00K | -40.00K | |||
| Income Before Taxes | -86.48M | -69.13M | -55.33M | -26.29M | -9.34M | |||
| Income Tax | 0.00 | N/A | N/A | N/A | N/A | |||
| Net Income | -86.48M | -69.13M | -55.33M | -26.29M | -9.34M | |||
| EBITDA | -103.66M | -79.59M | -58.63M | -26.15M | -9.25M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.51 | -1.62 | -1.32 | -0.63 | -0.24 | |||
| Non GAAP EPS | -1.51 | -1.61 | -1.33 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD